A simple model for predicting lung cancer occurrence in a lung cancer screening program: The Pittsburgh Predictor

Lung Cancer

Volumn 89, Issue 1, 2015, Pages 31-37

  Wilson, David O ^a   Weissfeld, Joel ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

LDCT; Lung cancer; Lung cancer risk prediction; Lung cancer screening; Pittsburgh Predictor; PLuSS

Indexed keywords

ASBESTOS;

ADULT; ARTICLE; BODY MASS; CANCER RISK; CANCER SCREENING; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSESSMENT; FEMALE; FOLLOW UP; GROUPS BY AGE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PITTSBURGH PREDICTOR; PREDICTION; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; SMOKING; SMOKING CESSATION; THORAX RADIOGRAPHY; AGE; AGED; AREA UNDER THE CURVE; DIAGNOSTIC IMAGING; EARLY CANCER DIAGNOSIS; LUNG TUMOR; PATIENT SELECTION; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC; STATISTICAL MODEL; TIME FACTOR; X-RAY COMPUTED TOMOGRAPHY;

AGE FACTORS; AGED; AREA UNDER CURVE; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MODELS, STATISTICAL; PATIENT SELECTION; RISK ASSESSMENT; ROC CURVE; SMOKING; SURVEYS AND QUESTIONNAIRES; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84931560755     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2015.03.021     Document Type: Article

References (19)

1. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013, 63:11-30.
2. Aberle D.R., Adams A.M., Berg C.D., Black W.C., Clapp J.D., Fagerstrom R.M., et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011, 365:395-409. National Lung Screening Trial Research Team.
3. de Koning H.J., Meza R., Plevritis S.K., ten Haaf K., Munshi V.N., Jean J., et al. Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force. Ann Intern Med 2014, 160:311-320.
4. Humphrey L.L., Deffebach M., Pappas M., Baumann C., Artis K., Mitchell J.P., et al. Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive services task force recommendation. Ann Intern Med 2013, 159:411-420.
5. Bach P.B., Kattan M.W., Thornquist M.D., Kris M.G., Tate R.C., Barnett M.J., et al. Variations in lung cancer risk among smokers. J Natl Cancer Inst 2003, 95:470-478.
6. Cassidy A., Myles J.P., van Tongeren M., Page R.D., Liloglou T., Duffy S.W., et al. The LLP risk model: an individual risk prediction model for lung cancer. Br J Cancer 2008, 98:270-276.
7. Maisonneuve P., Bagnardi V., Bellomi M., Spaggiari L., Pelosi G., Rampinelli C., et al. Lung cancer risk prediction to select smokers for screening CT - a model based on the Italian COSMOS trial. Cancer Prev Res (Phila) 2011, 4:1778-1789.
8. Spitz M.R., Etzel C.J., Dong Q., Amos C.I., Wei Q., Wu X., et al. An expanded risk prediction model for lung cancer. Cancer Prev Res (Phila) 2008, 1:250-254.
9. Spitz M.R., Hong W.K., Amos C.I., Wu X., Schabath M.B., Dong Q., et al. A risk model for prediction of lung cancer. J Natl Cancer Inst 2007, 99:715-726.
10. Tammemagi C.M., Pinsky P.F., Caporaso N.E., Kvale P.A., Hacking W.G., Church T.R., et al. Lung cancer risk prediction: Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial models and validation. J Natl Cancer Inst 2011, 103:1058-1068.
11. Tammemagi M.C., Katki H.A., Hocking W.G., Church T.R., Caporaso N., Kvale P.A., et al. Selection criteria for lung-cancer screening. N Engl J Med 2013, 368:728-736.
12. Aberle D.R., Berg C.D., Black W.C., Clapp J.D., Fagerstrom R.M., Gareen I.F., et al. The National Lung Screening Trial: overview and study design. Radiology 2011, 258:243-253. National Lung Screening Trial Research Team.
13. Church T.R., Black W.C., Aberle D.R., Berg C.D., Clingan K.L., Duan F., et al. Results of initial low-dose computed tomographic screening for lung cancer. N Engl J Med 2013, 368:1980-1991. National Lung Screening Trial Research Team.
14. Wilson D.O., Weissfeld J.L., Fuhrman C.R., Fisher S., Balogh P., Landreneau R., et al. The Pittsburgh Lung Screening Study (PLuSS): outcomes within 3 years of a first computed tomography scan. Am J Respir Crit Care Med 2008, 178:956-961.
15. Hosmer D.W., Hosmer T., Le Cessie S., Lemeshow S. A comparison of goodness-of-fit tests for the logistic regression model. Stat Med 1997, 16:965-980.
16. Pencina M.J., D'Agostino R.B., D'Agostino R.B., Vasan R.S. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008, 27:157-172. discussion 207-12.
17. Vickers A.J., Elkin E.B. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Mak 2006, 26:565-574.
18. Ma J., Ward E.M., Smith R., Jemal A. Annual number of lung cancer deaths potentially avertable by screening in the United States. Cancer 2013, 119:1381-1385.
19. Kovalchik S.A., Tammemagi M., Berg C.D., Caporaso N.E., Riley T.L., Korch M., et al. Targeting of low-dose CT screening according to the risk of lung-cancer death. N Engl J Med 2013, 369:245-254.